86 related articles for article (PubMed ID: 11911807)
1. Intracellular redistribution of interferon-inducible proteins Nmi and IFP 35 in apoptotic cells.
Chen J; Naumovski L
J Interferon Cytokine Res; 2002 Feb; 22(2):237-43. PubMed ID: 11911807
[TBL] [Abstract][Full Text] [Related]
2. Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35.
Chen J; Shpall RL; Meyerdierks A; Hagemeier M; Böttger EC; Naumovski L
J Biol Chem; 2000 Nov; 275(46):36278-84. PubMed ID: 10950963
[TBL] [Abstract][Full Text] [Related]
3. A cytoplasmic structure resembling large protein aggregates induced by interferons.
Meyerdierks A; Denecke B; Rohde M; Taparowsky EJ; Böttger EC
J Histochem Cytochem; 1999 Feb; 47(2):169-82. PubMed ID: 9889253
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization of interferon-inducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35 homologous domain.
Lee ND; Chen J; Shpall RL; Naumovski L
J Interferon Cytokine Res; 1999 Nov; 19(11):1245-52. PubMed ID: 10574616
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha induces nmi-IFP35 heterodimeric complex formation that is affected by the phosphorylation of IFP35.
Zhou X; Liao J; Meyerdierks A; Feng L; Naumovski L; Bottger EC; Omary MB
J Biol Chem; 2000 Jul; 275(28):21364-71. PubMed ID: 10779520
[TBL] [Abstract][Full Text] [Related]
6. Interferon-induced upregulation and cytoplasmic localization of Myc-interacting protein Nmi.
Lebrun SJ; Shpall RL; Naumovski L
J Interferon Cytokine Res; 1998 Sep; 18(9):767-71. PubMed ID: 9781816
[TBL] [Abstract][Full Text] [Related]
7. IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution.
Bange FC; Vogel U; Flohr T; Kiekenbeck M; Denecke B; Böttger EC
J Biol Chem; 1994 Jan; 269(2):1091-8. PubMed ID: 8288566
[TBL] [Abstract][Full Text] [Related]
8. IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors.
Wang X; Johansen LM; Tae HJ; Taparowsky EJ
Biochem Biophys Res Commun; 1996 Dec; 229(1):316-22. PubMed ID: 8954125
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of Nmi, a novel partner of Myc proteins.
Bao J; Zervos AS
Oncogene; 1996 May; 12(10):2171-6. PubMed ID: 8668343
[TBL] [Abstract][Full Text] [Related]
10. Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN.
Bannasch D; Weis I; Schwab M
Oncogene; 1999 Nov; 18(48):6810-7. PubMed ID: 10597290
[TBL] [Abstract][Full Text] [Related]
11. The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling.
Zhang L; Tang Y; Tie Y; Tian C; Wang J; Dong Y; Sun Z; He F
Cell Signal; 2007 May; 19(5):932-44. PubMed ID: 17197158
[TBL] [Abstract][Full Text] [Related]
12. Stability of Nmi protein is controlled by its association with Tip60.
Zhang K; Zheng G; Yang YC
Mol Cell Biochem; 2007 Sep; 303(1-2):1-8. PubMed ID: 17406968
[TBL] [Abstract][Full Text] [Related]
13. GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis.
Essmann F; Wieder T; Otto A; Müller EC; Dörken B; Daniel PT
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):777-83. PubMed ID: 10698706
[TBL] [Abstract][Full Text] [Related]
14. DEDD regulates degradation of intermediate filaments during apoptosis.
Lee JC; Schickling O; Stegh AH; Oshima RG; Dinsdale D; Cohen GM; Peter ME
J Cell Biol; 2002 Sep; 158(6):1051-66. PubMed ID: 12235123
[TBL] [Abstract][Full Text] [Related]
15. Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1.
McConnell BB; Vertino PM
Cancer Res; 2000 Nov; 60(22):6243-7. PubMed ID: 11103777
[TBL] [Abstract][Full Text] [Related]
16. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA.
Kalai M; Van Loo G; Vanden Berghe T; Meeus A; Burm W; Saelens X; Vandenabeele P
Cell Death Differ; 2002 Sep; 9(9):981-94. PubMed ID: 12181749
[TBL] [Abstract][Full Text] [Related]
17. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
Ozören N; El-Deiry WS
Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
[TBL] [Abstract][Full Text] [Related]
18. Activation of intrinsic and extrinsic pathways in apoptotic signaling during UV-C-induced death of Jurkat cells: the role of caspase inhibition.
Scoltock AB; Cidlowski JA
Exp Cell Res; 2004 Jul; 297(1):212-23. PubMed ID: 15194437
[TBL] [Abstract][Full Text] [Related]
19. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
20. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes.
Déas O; Dumont C; MacFarlane M; Rouleau M; Hebib C; Harper F; Hirsch F; Charpentier B; Cohen GM; Senik A
J Immunol; 1998 Oct; 161(7):3375-83. PubMed ID: 9759854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
